An Investigational Immuno-therapy Study Of Nivolumab In Combination With Trametinib With Or Without Ipilimumab In Participants With Previously Treated Cancer of the Colon or Rectum That Has Spread
Clinical trial NCT03377361 · COMPLETED
Trial details
- NCT number
- NCT03377361
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-01-31
- Primary completion
- 2024-11-04
- Enrollment
- 325
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.